A Study to Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited Metastatic Colorectal Cancer: a Single-center, Phase 2 Study
Clinical trial NCT05954429 · RECRUITING
Trial details
- NCT number
- NCT05954429
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-20
- Primary completion
- 2026-12-28
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.